ArticleJournal of family medicine and primary care2024
Distribution of extrapulmonary tuberculosis in CBNAAT samples received in a tertiary care hospital - A record-based study.
Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary tuberculosis (PTB) accounts for 85% of all reported tuberculosis cases globally. Extrapulmonary involvement can occur in isolation or along with a pulmonary focus as in the case of patients with disseminated tuberculosis (TB). EPTB can occur through hematogenous, lymphatic, or localized bacillary dissemination from a primary source, such as PTB and affects the brain, eye, mouth, tongue, lymph nodes of neck, spine, bones, muscles, skin, pleura, pericardium, gastrointestinal, peritoneum and the genitourinary system as primary and/or disseminated disease. Although pulmonary TB is the most common presentation, EPTB is also an important problem clinically. Cartridge-based nucleic acid amplification (CBNAAT) test has a well-documented role in diagnosing pulmonary tuberculosis. Aim: To determine the distribution of EPTB in various samples received for CBNAAT testing in our Institution. Methods: In this retrospective cross-sectional study, data of suspected EPTB patients were retrieved and analyzed from January 2020 to December 2022. Statistical Analysis: All the statistical analyses were carried out using the Excel spreadsheet and Open-epi version 3.01 platform. Results: A total number of 1118(n) extrapulmonary samples were processed using GeneXpert MTB/RIF assay. Out of the 1118 received samples, (22%) were positive. Among the 249 positive samples, 55% samples were received from the female patients and 45% samples received from the male patients. We found that most MTB positive samples were from this age group (i.e. 21-30). Most common sample received for processing was Lymph node aspirate accounting to 37% followed by pleural fluid (30%), pus (8%) and gastric lavage amounting for 4% along with other miscellaneous samples making up the others to 21%. Out of 249 MTB detected samples, 47% were from lymph node aspirate, 13% from pleural fluid, 12% from pus, 3% from gastric lavage and 25% from other samples. We noted that the majority of the positive cases were rifampicin sensitive (97.68%). Conclusion: Results of our study suggest that younger age (third decade of life) and female gender may be independent risk factors for EPTB. In developing countries, the prevalence of EPTB is relatively lower than PTB but still it is an important cause of morbidity and mortality. Thus, early diagnosis and initiation of appropriate treatment are important for reducing the case load. Women especially should be investigated thoroughly for EPTB and BCG vaccination should be encouraged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.